Anti-cancer activity of phenyl and pyrid-2-yl 1,3-substituted benzo[1,2,4]triazin-7-ones and stable free radical precursors

  • Lee Ann J. Keane
  • , Styliana I. Mirallai
  • , Martin Sweeney
  • , Michael P. Carty
  • , Georgia A. Zissimou
  • , Andrey A. Berezin
  • , Panayiotis A. Koutentis
  • , Fawaz Aldabbagh

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

10 Citations (Scopus)

Abstract

Cell viability studies for benzo[1,2,4]triazin-7-ones and 1,2,4-benzotriazinyl (Blatter-type) radical precursors are described with comparisons made with 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO). All of the stable free radicals were several orders of magnitude less cytotoxic than the benzo[1,2,4] triazin-7-ones. The synthesis and evaluation of two new pyrid-2-yl benzo[1,2,4] triazin-7-ones are described, where altering the 1,3-substitution from phenyl to pyrid-2-yl increased cytotoxicity against most cancer cell lines, as indicated using National Cancer Institute (NCI) one-dose testing. COMPARE analysis of five-dose testing data from the NCI showed very strong correlations to the naturally occurring anti-cancer compound pleurotin. COMPARE is program, which analyzes similarities in cytotoxicity data of compounds, and enables quantitative expression as Pearson correlation coefficients. Compounds were also evaluated using the independent MTT assay, which was compared with SRB assay data generated at the NCI.

Original languageEnglish
Article number574
JournalMolecules
Volume23
Issue number3
DOIs
Publication statusPublished - 2018

Keywords

  • Anti-tumour
  • Blatter-type radical
  • Heterocyclic compound
  • NCI
  • Pleurotin
  • TEMPO

Fingerprint

Dive into the research topics of 'Anti-cancer activity of phenyl and pyrid-2-yl 1,3-substituted benzo[1,2,4]triazin-7-ones and stable free radical precursors'. Together they form a unique fingerprint.

Cite this